13 results
·
21ms
·
Sources: EU EUDAMED, US FDA
TroClose 1200
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
UNIVERSAL NEURO 2
FDA UDI
Stryker Leibinger GmbH & Co. KG·07613154598922·BURR HOLE COVER PLATE WITH TAB, 30mm
ceraMotion®
FDA UDI
DENTAURUM GmbH & Co.KG·J011253620020·ceraMotion® Lf Body Stains A, 2 g / dental cera...
Truliant
FDA UDI
Exactech, Inc.·10885862556820·TRIAL, TIBIAL INSERT, PSC, SIZE 2
Aneroid Sphygmomanometer
FDA 510(k)
FDA Class 2
·Cardiovascular
Enovare Ultrasound System
FDA 510(k)
FDA Class 2
·Radiology
DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code QBJ·September 10, 2025
AED PLUS
FDA Adverse Event
Malfunction
·ZOLL MEDICAL CORP·Product code MKJ·August 11, 2011
VITALITY EL
FDA Adverse Event
Malfunction
·CARDIAC PACEMAKERS, INC·Product code LWS·November 11, 2008
SPECTRUM INFUSION PUMP
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE CORP.·Product code FRN·July 15, 2013
M2A-38 CUP 52MM
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code KWA·December 27, 2018
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014